Aminologics Co Ltd
KOSDAQ:074430
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aminologics Co Ltd
Interest Income Expense
Aminologics Co Ltd
Interest Income Expense Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aminologics Co Ltd
KOSDAQ:074430
|
Interest Income Expense
₩1B
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SK IE Technology Co Ltd
KRX:361610
|
Interest Income Expense
₩19.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hansol Chemical Co Ltd
KRX:014680
|
Interest Income Expense
₩23.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dongjin Semichem Co Ltd
KOSDAQ:005290
|
Interest Income Expense
-₩5.2B
|
CAGR 3-Years
31%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
13%
|
|
|
S
|
SoulBrain Co Ltd
KOSDAQ:357780
|
Interest Income Expense
₩30.5B
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Isu Specialty Chemical Co Ltd
KRX:457190
|
Interest Income Expense
-₩6.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Aminologics Co Ltd
Glance View
Aminologics Co., Ltd. engages in the manufacture and sale of amino acids and amino acid derivatives. The company is headquartered in Seoul, Seoul. The company went IPO on 2004-06-04. is a Korea-based company mainly engaged in the manufacture and distribution of image processing chips for digital video recorders (DVRs). The firm operates its business through in two divisions: information technology (IT) division and amino acid division. Its IT division engages in the manufacture of DVR system-on-chips (SoCs), analog and digital integrated chips, multiplexer and display chips, color quad chips, video codec, peripheral component interconnect (PCI) one chips and others. Its amino acid division produces unnatural amino acids, which are used for pharmaceutical development. On July 29, 2013, the Company sold its entire shares of U-CHANG PLANT CONSTRUCTION CO., LTD. On December 23, 2013, Sam-Oh Pharm Co Ltd became the largest shareholder of the Company by acquiring a 16.67% stake in the Company.
See Also
What is Aminologics Co Ltd's Interest Income Expense?
Interest Income Expense
1B
KRW
Based on the financial report for Dec 31, 2025, Aminologics Co Ltd's Interest Income Expense amounts to 1B KRW.
What is Aminologics Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
67%
Over the last year, the Interest Income Expense growth was -48%. The average annual Interest Income Expense growth rates for Aminologics Co Ltd have been 67% over the past three years .
